Production (Stage)
ArriVent BioPharma, Inc.
AVBP
$20.40
-$0.23-1.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 176.08M | 218.86M | 282.86M | 298.67M | 317.39M |
| Total Receivables | 505.00K | 500.00K | 500.00K | 750.00K | 875.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.23M | 407.00K | 1.14M | 1.23M | 1.45M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.98M | 7.21M | 7.90M | 7.87M | 7.76M |
| Total Current Assets | 185.79M | 226.98M | 292.40M | 308.51M | 327.48M |
|
|
|||||
| Total Current Assets | 185.79M | 226.98M | 292.40M | 308.51M | 327.48M |
| Net Property, Plant & Equipment | 120.00K | 154.00K | 187.00K | 219.00K | 250.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 176.00K | 126.00K | 126.00K | 125.00K | 108.00K |
| Total Assets | 215.50M | 274.94M | 292.71M | 308.86M | 327.84M |
|
|
|||||
| Total Accounts Payable | 4.36M | 3.78M | 4.65M | 3.81M | 4.10M |
| Total Accrued Expenses | 8.45M | 13.33M | 10.36M | 8.13M | 5.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 138.00K | 162.00K | 157.00K | 152.00K | 147.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.95M | 17.27M | 15.16M | 12.10M | 9.98M |
|
|
|||||
| Total Current Liabilities | 12.95M | 17.27M | 15.16M | 12.10M | 9.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 14.00K | 56.00K | 98.00K | 138.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.95M | 17.29M | 15.22M | 12.20M | 10.12M |
|
|
|||||
| Common Stock & APIC | 505.28M | 496.20M | 495.19M | 493.80M | 492.99M |
| Retained Earnings | -302.72M | -238.33M | -217.70M | -197.14M | -175.26M |
| Treasury Stock & Other | -17.00K | -211.00K | -- | -- | -- |
| Total Common Equity | 202.54M | 257.65M | 277.49M | 296.66M | 317.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 202.54M | 257.65M | 277.49M | 296.66M | 317.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 202.54M | 257.65M | 277.49M | 296.66M | 317.72M |
|
|
|||||